(Q27011652)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

1 reference

1 reference

Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

0 references

1 reference

irritable bowel syndrome

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

Keith A. Sharkey

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

author name string

M Bashashati

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

H Bashashati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

A Shafieyoun

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

N E Daryani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

M Storr

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

language of work or name

1 reference

16 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

Neurogastroenterology and Motility

11 February 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

volume

24

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

issue

12

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

11 February 2020

page(s)

1102-e566

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22897390%20AND%20SRC:MED&resulttype=core&format=json

Clinical practice. Irritable bowel syndrome

11 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Post-infectious irritable bowel syndrome--a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Sequelae of traveler's diarrhea: focus on postinfectious irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Cytokines and irritable bowel syndrome: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Are there alterations of neuroendocrine and cellular immune responses to nutrients in women with irritable bowel syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

T-cell activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Mechanism of cytokine modulation of epithelial tight junction barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Cells, cytokines and inflammatory bowel disease: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

G protein beta3 subunit, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in Koreans with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

A meta-analysis on the association between three promoter variants of TNF-α and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Immune dysfunction in patients with functional gastrointestinal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Serum and colonic mucosal immune markers in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Lower serum IL-10 is an independent predictor of IBS among volunteers in Mexico.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Mucosal cytokine imbalance in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Biology of interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Immune activation in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Effect of the polymorphism of tumor necrosis factor-alpha-308 G/A gene promoter on the susceptibility to ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Meta-analysis: polymorphisms in TNF-alpha gene promoter and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Inflammatory bowel disease in Asia: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Post-infectious irritable bowel syndrome: the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

IBS: An epigenetic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2012.01990.X